Prot# OSI-904-202: A Randomized, Open-Label, Phase II Study of OSI-7904L versus 5-FU/LV as First-Line Treatment in Patients with Unresectable, Locally Advanced or Metastatic Adenocarcinoma of the Biliary Tract

Project: Research project

Project Details

StatusFinished
Effective start/end date2/3/05 → 1/18/06

Funding

  • OSI Pharmaceuticals, Inc. (OSI-904-202)